To Homepage

Multicentre cross-sectional observational registry to monitor the safety of early discharge after rule-out of acute myocardial infarction by copeptin and troponin: the Pro-Core registry

Autoren: Giannitsis E, Clifford P, Slagman A, Ruedelstein R, Liebetrau C, Hamm C, Honnart D, Huber K, Vollert J, Simonelli C, Schröder M, Wiemer J, Mueller-Hennessen M, Schroer H, Kastner K, Möckel M
Source: http://dx.doi.org/10.1136/bmjopen-2018-028311
Indication: Cardiology
Access: Open Access
Product: Copeptin

There is sparse information on the safety of early primary discharge from the emergency department (ED) after rule-out of myocardial infarction in suspected acute coronary syndrome (ACS).
https://bmjopen.bmj.com/content/9/7/e028311.full

 

Not all products are CE marked or have 510(k) clearance for sale in the U.S. Availability of products in each country depends on local regulatory marketing authorization status.